Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Toho to Make Funabashi a 100%-Subsidiary
January 21, 2002
- Sumitomo Heavy Industries, GEYMS: FDG MicroLab
January 21, 2002
- Korosho to Make Full Effort to Develop Strong Drug Industry
January 21, 2002
- JPMA to Propose New NHI Drug Price System: JPMA President
January 21, 2002
- OTC NEWS IN BRIEF
January 21, 2002
- Drug Misuse Cases Reach 108 in 2000 with 12 Requiring Hospitalization
January 21, 2002
- Merck Hoei Aiming at Becoming No. 1 Generic House
January 21, 2002
- Private Advisory Board to Mull Medical Fee System to Be Set Up: Health Minister Sakaguchi
January 21, 2002
- BUSINESS NEWS IN BRIEF
January 21, 2002
- Toxicogenomics, Nanotechnology Stressed in 2002 Korosho Budget Requests
January 21, 2002
- Kyowa Hakko Succeeds in Producing Antibodies with High ADCC
January 21, 2002
- Wholesalers Environment to Be Tougher This Year: EAD Director
January 21, 2002
- First Survey on Diabetic Neuropathy Conducted in Japan: JPA
January 21, 2002
- NHI Price System Reform to Give Incentives to New Drugs: PFSB Director General
January 21, 2002
- Korosho Starts Research to Clarify Causes of 3 Severe ADRs
January 21, 2002
- Birth Rate Lowest Ever Recorded, Continuing Trend of Fewer Children
January 21, 2002
- University of Tokyo to Abolish Master Degree System
January 21, 2002
- REGULATORY NEWS IN BRIEF
January 21, 2002
- Criteria for Compensation for AE Sustained in Clinical Trials Needed: JSCPT
January 21, 2002
- Foreign Firm Are Enthusiastic about Increasing Number of MRs: Survey
January 21, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…